Bacterial Metabolites Influence Colorectal Cancer and Immunotherapy

A new review highlights that *Fusobacterium nucleatum* metabolites are key drivers in colorectal cancer progression and patient response to immunotherapy. These small molecules reprogram inflammatory signaling, alter tumor-cell metabolism, and remodel immune cell epigenetics. This research offers a conceptual shift in understanding microbial pathogenicity in cancer.